148 related articles for article (PubMed ID: 35187463)
1. Sparing the Prod: Providing an Alternative to Endomyocardial Biopsies With Noninvasive Surveillance After Heart Transplantation During COVID-19.
Amadio JM; Rodenas-Alesina E; Superina S; Kozuszko S; Tsang K; Simard A; Aleksova N; Kobulnik J; Fan CS; Wijeysundera HC; Ross HJ; McDonald MA; Duero Posada JG; Moayedi Y
CJC Open; 2022 May; 4(5):479-487. PubMed ID: 35187463
[TBL] [Abstract][Full Text] [Related]
2. Initiation of noninvasive surveillance for allograft rejection in heart transplant patients > 1 year after transplant.
Kewcharoen J; Kim J; Cummings MB; Leitner KB; Suzuki EMB; Banerjee D; Lum CJ
Clin Transplant; 2022 Mar; 36(3):e14548. PubMed ID: 34843112
[TBL] [Abstract][Full Text] [Related]
3. Single-center utilization of donor-derived cell-free DNA testing in the management of heart transplant patients.
Gondi KT; Kao A; Linard J; Austin BA; Everley MP; Fendler TJ; Khumri T; Lawhorn SL; Magalski A; Nassif ME; Sperry BW; Vodnala D; Borkon AM
Clin Transplant; 2021 May; 35(5):e14258. PubMed ID: 33606316
[TBL] [Abstract][Full Text] [Related]
4. Surveillance with dual noninvasive testing for acute cellular rejection after heart transplantation: Outcomes from the Surveillance HeartCare Outcomes Registry.
Khush K; Hall S; Kao A; Raval N; Dhingra R; Shah P; Bellumkonda L; Ravichandran A; Van Bakel A; Uriel N; Patel S; Pinney S; DePasquale E; Baran DA; Pinney K; Oreschak K; Kobulnik J; Shen L; Teuteberg J
J Heart Lung Transplant; 2024 May; ():. PubMed ID: 38759766
[TBL] [Abstract][Full Text] [Related]
5. Short-term clinical outcomes and predicted cost savings of dd-cfDNA-led surveillance after pediatric heart transplantation.
Feingold B; Rose-Felker K; West SC; Miller SA; Zinn MD
Clin Transplant; 2023 May; 37(5):e14933. PubMed ID: 36779524
[TBL] [Abstract][Full Text] [Related]
6. Early findings after integration of donor-derived cell-free DNA into clinical care following pediatric heart transplantation.
Feingold B; Rose-Felker K; West SC; Zinn MD; Berman P; Moninger A; Huston A; Stinner B; Xu Q; Zeevi A; Miller SA
Pediatr Transplant; 2022 Feb; 26(1):e14124. PubMed ID: 34420244
[TBL] [Abstract][Full Text] [Related]
7. A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantation.
Kim PJ; Olymbios M; Siu A; Wever Pinzon O; Adler E; Liang N; Swenerton R; Sternberg J; Kaur N; Ahmed E; Chen YA; Fehringer G; Demko ZP; Billings PR; Stehlik J
J Heart Lung Transplant; 2022 Jul; 41(7):919-927. PubMed ID: 35577713
[TBL] [Abstract][Full Text] [Related]
8. Combining donor derived cell free DNA and gene expression profiling for non-invasive surveillance after heart transplantation.
Henricksen EJ; Moayedi Y; Purewal S; Twiggs JV; Waddell K; Luikart H; Han J; Feng K; Wayda B; Lee R; Shudo Y; Jimenez S; Khush KK; Teuteberg JJ
Clin Transplant; 2023 Mar; 37(3):e14699. PubMed ID: 35559582
[TBL] [Abstract][Full Text] [Related]
9. The End of Endomyocardial Biopsy?: A Practical Guide for Noninvasive Heart Transplant Rejection Surveillance.
Holzhauser L; DeFilippis EM; Nikolova A; Byku M; Contreras JP; De Marco T; Hall S; Khush KK; Vest AR
JACC Heart Fail; 2023 Mar; 11(3):263-276. PubMed ID: 36682960
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two donor-derived cell-free DNA tests and a blood gene-expression profile test in heart transplantation.
Rodgers N; Gerding B; Cusi V; Vaida F; Tada Y; Morris GP; Adler ED; Stehlik J; Kim PJ
Clin Transplant; 2023 Jun; 37(6):e14984. PubMed ID: 37036133
[TBL] [Abstract][Full Text] [Related]
11. The utilization of molecular microscope in management of heart transplant recipients in the era of noninvasive monitoring.
Mehlman Y; Valledor AF; Moeller C; Rubinstein G; Lotan D; Rahman S; Oh KT; Bae D; DeFilippis EM; Lin EF; Lee SH; Raikhelkar JK; Fried J; Theodoropoulos K; Colombo PC; Yuzefpolskaya M; Latif F; Clerkin KJ; Sayer GT; Uriel N
Clin Transplant; 2023 Dec; 37(12):e15131. PubMed ID: 37897211
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study.
Khush KK; Patel J; Pinney S; Kao A; Alharethi R; DePasquale E; Ewald G; Berman P; Kanwar M; Hiller D; Yee JP; Woodward RN; Hall S; Kobashigawa J
Am J Transplant; 2019 Oct; 19(10):2889-2899. PubMed ID: 30835940
[TBL] [Abstract][Full Text] [Related]
13. Local laboratory-run donor-derived cell-free DNA assay for rejection surveillance in heart transplantation-first six months of clinical experience.
Teszak T; Bödör C; Hegyi L; Levay L; Nagy B; Fintha A; Merkely B; Sax B
Clin Transplant; 2023 Sep; 37(9):e15078. PubMed ID: 37489087
[TBL] [Abstract][Full Text] [Related]
14. Protocol-based donor-derived cell-free DNA surveillance in kidney transplant recipients: A single-center experience.
Nissaisorakarn P; Patel H; Amtul A; Pavlakis M
Clin Nephrol; 2022 Aug; 98(2):65-74. PubMed ID: 35445660
[TBL] [Abstract][Full Text] [Related]
15. Comparing Plasma Donor-derived Cell-free DNA to Gene Expression in Endomyocardial Biopsies in the Trifecta-Heart Study.
Halloran PF; Reeve J; Mackova M; Madill-Thomsen KS; Demko Z; Olymbios M; Campbell P; Melenovsky V; Gong T; Hall S; Stehlik J
Transplantation; 2024 Mar; ():. PubMed ID: 38538559
[TBL] [Abstract][Full Text] [Related]
16. HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study.
Sorbini M; Togliatto GM; Simonato E; Boffini M; Cappuccio M; Gambella A; Arruga F; Mora N; Marro M; Caorsi C; Mansouri M; Magistroni P; Delsedime L; Papotti MG; Amoroso A; Rinaldi M; Vaisitti T; Deaglio S
J Heart Lung Transplant; 2021 Aug; 40(8):794-804. PubMed ID: 34134912
[TBL] [Abstract][Full Text] [Related]
17. Donor-derived cell-free DNA as a composite marker of acute lung allograft dysfunction in clinical care.
Keller M; Sun J; Mutebi C; Shah P; Levine D; Aryal S; Iacono A; Timofte I; Mathew J; Varghese A; Giner C; Agbor-Enoh S
J Heart Lung Transplant; 2022 Apr; 41(4):458-466. PubMed ID: 35063338
[TBL] [Abstract][Full Text] [Related]
18. Donor-derived cell-free DNA (dd-cfDNA) for detection of allograft rejection in pediatric kidney transplants.
Puliyanda DP; Swinford R; Pizzo H; Garrison J; De Golovine AM; Jordan SC
Pediatr Transplant; 2021 Mar; 25(2):e13850. PubMed ID: 33217125
[TBL] [Abstract][Full Text] [Related]
19. Use of Donor-derived Cell-free DNA to Inform Tapering of Immunosuppression Therapy in Kidney Transplant Recipients: An Observational Study.
Osuchukwu G; Trevino A; McCormick S; Kaur N; Prigmore B; Al Haj Baddar N; Bloom MS; Demko Z; Gauthier P
Transplant Direct; 2024 Apr; 10(4):e1610. PubMed ID: 38481964
[TBL] [Abstract][Full Text] [Related]
20. Combining Blood Gene Expression and Cellfree DNA to Diagnose Subclinical Rejection in Kidney Transplant Recipients.
Park S; Guo K; Heilman RL; Poggio ED; Taber DJ; Marsh CL; Kurian SM; Kleiboeker S; Weems J; Holman J; Zhao L; Sinha R; Brietigam S; Rebello C; Abecassis MM; Friedewald JJ
Clin J Am Soc Nephrol; 2021 Oct; 16(10):1539-1551. PubMed ID: 34620649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
